Stroke is a leading cause of disability, dementia and death worldwide. Approximately 70% of
deaths from stroke and 87% of stroke-related disability occur in low-income and middle …

Sickle cell disease is an autosomal recessive disorder of the beta-globin gene, with resultant
deformation of the red blood cells and variable clinical outcomes. Nigeria is recognised as …

Sickle cell disease (SCD) is the most common clinically significant hemoglobinopathy,
characterized by painful episodes, anemia, high risk of infection, and other acute and …

Background: Sickle cell disease (SCD) continues to pose physical and psychosocial
burdens to patients, caregivers and health workers. Stakeholder engagement in the …

Disease registries can be extremely powerful evidence generating tools while providing a
central meeting point for all implicated stakeholders, facilitating their networking and …

Introduction: Hydroxyurea (HU) has been shown to be beneficial in the management of
sickle cell disease (SCD) as it improves treatment outcomes. However, despite the benefits …

Sickle cell disease (SCD) is a prevalent inherited blood disorder, particularly affecting
populations in Africa. This review examined the disease's burden, its diverse clinical …

Background Despite the proven efficacy of evidence-based healthcare interventions in
reducing adverse outcomes and mortality associated with Sickle Cell Disease (SCD), a vast …

Skills development, the building of human capacity, is key to any sustainable capacity
building effort, however, such undertakings require adaptable and tailored strategies. The …

Background Sickle cell disease (SCD) is a severe hereditary form of anemia that contributes
between 50% and 80% of under-five mortality in Africa. Eleven thousand babies are born …